Breast CarePub Date : 2024-08-08DOI: 10.1159/000540749
Yixuan Zhang, Lin Han, Yang Rui, Chunchang Zhang, Sasa Duan, Pan Li, Jie Hou
{"title":"Acupuncture for Aromatase Inhibitor-Induced Arthralgia in Breast Cancer: An Umbrella Review","authors":"Yixuan Zhang, Lin Han, Yang Rui, Chunchang Zhang, Sasa Duan, Pan Li, Jie Hou","doi":"10.1159/000540749","DOIUrl":"https://doi.org/10.1159/000540749","url":null,"abstract":"Abstract\u0000Background: Acupuncture therapy shows promise in managing aromatase inhibitor-induced arthralgia (AIA) among breast cancer patients. An umbrella review synthesizes findings from systematic reviews and meta-analyses (SRs/MAs) to assess its effectiveness. Summary: This umbrella review aims to evaluate the effectiveness of acupuncture therapy in treating AIA among breast cancer patients by analyzing existing evidence from SRs/MAs. Key Messages: Evidence Evaluation: Six SRs/MAs were analyzed, revealing shortcomings in reporting quality, methodological quality, and evidence quality assessment.Methodological Analysis: Comprehensive searches across eight electronic databases were conducted. PRISMA, AMSTAR 2, and GRADE were utilized to assess reporting, methodological quality, and evidence quality, respectively.\u0000Efficacy of Acupuncture: Despite methodological shortcomings, recent meta-subgroup analysis suggests the efficacy of acupuncture therapy for AIA patients, recommending a 10-session treatment course. Conclusion: Acupuncture is identified as a secure and effective remedy for AIA sufferers, yet further high-quality research is needed to strengthen the evidence base and endorse acupuncture as a viable treatment option.\u0000","PeriodicalId":504260,"journal":{"name":"Breast Care","volume":"115 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141926102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Patient satisfaction, aesthetic outcome and quality of life in Oncoplastic and reconstructive breast surgery – a single center experience","authors":"M. Bolliger, Luca Gambone, Theresa Haeusler, Fanny Mikula, Stephanie Kampf, Florian Fitzal","doi":"10.1159/000540037","DOIUrl":"https://doi.org/10.1159/000540037","url":null,"abstract":"Background: Oncoplastic surgery has become an important part of the surgical repertoire to offer both oncologically safe and aesthetically pleasing results in patients with breast cancer. \u0000Data comparing oncoplastic and reconstructive breast surgeries are limited.\u0000This study aimed to assess patient-reported outcomes (PRO) in our cohort of oncoplastic and reconstructively operated patients.\u0000Methods: Patients who underwent oncoplastic surgery, including immediate reconstruction by a single surgeon, between 2010 and 2018 were contacted to participate in this study. In total, 157 patients fulfilled the inclusion criteria. 54 patient data sets were used for statistical evaluation. Body Image Scale (BIS) and BreastQ questionnaires were used to measure subjective PRO scores, and pictures were taken to objectively measure symmetry using the Breast Analysis Tool (BAT). Patients were divided into three groups according to the Tübingen classification (Group 1: Tübingen 3-4 (n=16), Group 2: Tübingen 5 (n=26), Group 3: Breast Reconstruction/Tübingen 6 (n=12] ).\u0000Results: The mean age was 53.5 for Group 1, 51.4 for Group 2 and 46.8 for Group 3. The mean follow-up was 62.9 +/- 35.82 months. BIS was significantly better in Group 3 (3.92±1.73) than in Group 1 and 2 (7.69±4.48 and 4.81±3.41, p=0.016). Symmetry measured using BAT showed only a trend favoring reconstruction (p=0.12). The BreastQ item “Sexual well-being was significantly better in oncoplastic breast reduction surgery (p=0.036). \u0000Conclusion: BIS was better after reconstructive breast surgery than after oncoplastic surgery.\u0000Reconstructive breast surgery in experienced breast care units offers high patient satisfaction and a high quality of life. \u0000","PeriodicalId":504260,"journal":{"name":"Breast Care","volume":"67 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141817833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Breast CarePub Date : 2024-04-22DOI: 10.1159/000538940
Min Yao, Puchao Peng, X. Ding, Qinfang Sun, Lijie Chen
{"title":"Comparison of intermittent pneumatic compression pump as adjunct to decongestive lymphatic therapy against decongestive therapy alone for upper limb lymphedema after breast cancer surgery: A systematic review and meta-analysis","authors":"Min Yao, Puchao Peng, X. Ding, Qinfang Sun, Lijie Chen","doi":"10.1159/000538940","DOIUrl":"https://doi.org/10.1159/000538940","url":null,"abstract":"Background: Breast cancer is among the most prevalent malignancies in women worldwide, with substantial morbidity and mortality. Upper limb lymphedema (ULL) is a common complication after breast cancer surgery that affects patients' daily activities and quality of life. Decongestive lymphatic therapy (DLT) and intermittent pneumatic compression (IPC) therapy are two primary treatment methods for ULL. \u0000Objectives: This study aims to compare the efficacy of DLT with IPC versus DLT alone in the management of ULL following breast cancer surgery. \u0000Method: PubMed Central, SCOPUS, EMBASE, MEDLINE, Cochrane trial registry, Google Scholar, and Clinicaltrials.gov databases were comprehensively searched for randomized controlled trials (RCTs) comparing DLT with IPC and DLT alone in patients with breast cancer-related ULL. Risk of bias was evaluated using the RoB 2 tool. Pooled effect sizes were calculated using random-effects models. \u0000Results: A total of 1894 citations were identified by the systematic search. Of them, 9 RCTs were included in the analysis. The pooled SMD for percentage volume reduction was 0.63 (95%CI: -0.24 to 1.50; I2=90.9%), showing no significant difference between the DLT alone and DLT combined with IPC (p=0.15). Pain and heaviness scores were also comparable between the groups. However, there was a significant difference in external rotation joint mobility (SMD=0.62; 95%CI: 0.08-1.16; I2=23.8%), favouring DLT with IPC. \u0000Conclusions: Our findings suggest that DLT with IPC and DLT alone showed similar findings in managing ULL after breast cancer surgery, with DLT with IPC showing a greater impact on external rotation joint mobility. Healthcare providers should consider patient preferences and individual factors when selecting the most appropriate treatment modality for ULL management.","PeriodicalId":504260,"journal":{"name":"Breast Care","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140677546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Breast CarePub Date : 2024-04-18DOI: 10.1159/000538596
Tjoung-Won Park-Simon, Volkmar Müller, Ute-Susann Albert, M. Banys-Paluchowski, I. Bauerfeind, J. Blohmer, Wilfried Budach, Peter Dall, N. Ditsch, Eva M. Fallenberg, Peter A. Fasching, T. Fehm, Michael Friedrich, B. Gerber, O. Gluz, Nadia Harbeck, A. Hartkopf, J. Heil, J. Huober, C. Jackisch, C. Kolberg-Liedtke, H. Kreipe, D. Krug, Thorsten Kühn, S. Kümmel, S. Loibl, Diana Lüftner, Michael Patrick Lux, Nicolai Maass, C. Mundhenke, T. Reimer, Kerstin Rhiem, Achim Rody, Marcus Schmidt, A. Schneeweiss, F. Schütz, H. Sinn, Christine Solbach, Erich-Franz Solomayer, E. Stickeler, Christoph Thomssen, M. Untch, Isabell Witzel, Rachel Würstlein, Achim Wöckel, Wolfgang Janni, Marc Thill
{"title":"AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer (EBC): Update 2024","authors":"Tjoung-Won Park-Simon, Volkmar Müller, Ute-Susann Albert, M. Banys-Paluchowski, I. Bauerfeind, J. Blohmer, Wilfried Budach, Peter Dall, N. Ditsch, Eva M. Fallenberg, Peter A. Fasching, T. Fehm, Michael Friedrich, B. Gerber, O. Gluz, Nadia Harbeck, A. Hartkopf, J. Heil, J. Huober, C. Jackisch, C. Kolberg-Liedtke, H. Kreipe, D. Krug, Thorsten Kühn, S. Kümmel, S. Loibl, Diana Lüftner, Michael Patrick Lux, Nicolai Maass, C. Mundhenke, T. Reimer, Kerstin Rhiem, Achim Rody, Marcus Schmidt, A. Schneeweiss, F. Schütz, H. Sinn, Christine Solbach, Erich-Franz Solomayer, E. Stickeler, Christoph Thomssen, M. Untch, Isabell Witzel, Rachel Würstlein, Achim Wöckel, Wolfgang Janni, Marc Thill","doi":"10.1159/000538596","DOIUrl":"https://doi.org/10.1159/000538596","url":null,"abstract":"Introduction: Each year the interdisciplinary AGO (Arbeitsgemeinschaft Gynäkologische Onkologie, German Gynecological Oncology Group) Breast Committee on Diagnosis and Treatment of Breast Cancer provides updated state-of-the-art recommendations for early and metastatic breast cancer.\u0000Methods: The updated evidence-based treatment recommendations for early and metastatic breast cancer have been released in March 2024. \u0000Results and Conclusion: This paper concisely captures the updated recommendations for early breast cancer chapter by chapter.\u0000","PeriodicalId":504260,"journal":{"name":"Breast Care","volume":" 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140686176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Breast CarePub Date : 2024-04-15DOI: 10.1159/000538816
Maximilian Moreth, N. Herröder, Petra Hödl, Alexa Bufe, Christiane Bretschneider, Volker Möbus, Joachim Rom, Markus Müller-Schimpfle
{"title":"Clinical axillary staging in breast cancer patients using ultrasound imaging","authors":"Maximilian Moreth, N. Herröder, Petra Hödl, Alexa Bufe, Christiane Bretschneider, Volker Möbus, Joachim Rom, Markus Müller-Schimpfle","doi":"10.1159/000538816","DOIUrl":"https://doi.org/10.1159/000538816","url":null,"abstract":"Introduction: The presence of axillary lymph node involvement is an important prognostic factor and has a major impact on treatment decisions in early breast cancer patients. This study aimed to determine the role of cortical thickness in axillary ultrasound (AUS) as an indicator of lymph node metastasis. Methods: 766 patients with primary breast cancer who received AUS during clinical work-up were selected for this retrospective study. Lymph nodes were defined as suspicious if they showed a cortical thickness of > 3,0 mm at 11-15 MHz harmonic imaging ultrasound. Lymph node involvement was assessed by core needle biopsy (n=150), sentinel node dissection or axillary dissection. Extensive axillary spread (EAS) was diagnosed if more than two lymph nodes showed metastatic disease on histology. Results: AUS for detecting all lymph node metastases had a sensitivity of 62,27 %, a specificity of 93,15 % and a negative predictive value of 81,74 %. However, the resulting negative predictive value for transcapsular growth was 93,97 %, and for extensive axillary spread 97,52 %. Conclusion: Extensive axillary spread - in contrast to non-palpable involvement of 1 or 2 lymph nodes - contributes relevantly to the individualization of breast cancer treatment. In combination with SNB, axillary ultrasound using cortical thickness as the main distinctive parameter seems to be an easily available, robust tool of diagnosing extensive axillary metastases. If axillary ultrasound proves negative, it helps to reduce the number of classic axillary dissections.","PeriodicalId":504260,"journal":{"name":"Breast Care","volume":"19 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140699228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Breast CarePub Date : 2024-04-10DOI: 10.1159/000538753
Marc Thill, Wolfgang Janni, Ute-Susann Albert, M. Banys-Paluchowski, I. Bauerfeind, J. Blohmer, Wilfried Budach, Peter Dall, N. Ditsch, Eva M. Fallenberg, Peter A. Fasching, T. Fehm, Michael Friedrich, B. Gerber, O. Gluz, Nadia Harbeck, A. Hartkopf, Jörg Heil, J. Huober, C. Jackisch, C. Kolberg-Liedtke, H. Kreipe, D. Krug, Thorsten Kühn, S. Kümmel, S. Loibl, Diana Lüftner, Michael Patrick Lux, Nicolai Maass, C. Mundhenke, T. Reimer, Kerstin Rhiem, Achim Rody, Marcus Schmidt, A. Schneeweiss, F. Schütz, H. Sinn, C. Solbach, Erich-Franz Solomayer, E. Stickeler, Christoph Thomssen, M. Untch, I. Witzel, Achim Wöckel, Rachel Würstlein, Volkmar Müller, Tjoung-Won Park-Simon
{"title":"AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024","authors":"Marc Thill, Wolfgang Janni, Ute-Susann Albert, M. Banys-Paluchowski, I. Bauerfeind, J. Blohmer, Wilfried Budach, Peter Dall, N. Ditsch, Eva M. Fallenberg, Peter A. Fasching, T. Fehm, Michael Friedrich, B. Gerber, O. Gluz, Nadia Harbeck, A. Hartkopf, Jörg Heil, J. Huober, C. Jackisch, C. Kolberg-Liedtke, H. Kreipe, D. Krug, Thorsten Kühn, S. Kümmel, S. Loibl, Diana Lüftner, Michael Patrick Lux, Nicolai Maass, C. Mundhenke, T. Reimer, Kerstin Rhiem, Achim Rody, Marcus Schmidt, A. Schneeweiss, F. Schütz, H. Sinn, C. Solbach, Erich-Franz Solomayer, E. Stickeler, Christoph Thomssen, M. Untch, I. Witzel, Achim Wöckel, Rachel Würstlein, Volkmar Müller, Tjoung-Won Park-Simon","doi":"10.1159/000538753","DOIUrl":"https://doi.org/10.1159/000538753","url":null,"abstract":"The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) presents the 2024 update of the evidence-based recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer (mBC).","PeriodicalId":504260,"journal":{"name":"Breast Care","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140717585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Breast CarePub Date : 2024-01-24DOI: 10.1159/000535997
N. Ditsch, M. Untch, Peter A. Fasching, Steffi Busch, Johannes Ettl, Renate Haidinger, C. Jackisch, Diana Lüftner, Lothar Müller, Volkmar Müller, Eugen Ruckhäberle, E. Schumacher-Wulf, Christoph Thomssen, Nadia Harbeck, Rachel Würstlein
{"title":"ABC7 Consensus: Assessment by a German Group of Experts","authors":"N. Ditsch, M. Untch, Peter A. Fasching, Steffi Busch, Johannes Ettl, Renate Haidinger, C. Jackisch, Diana Lüftner, Lothar Müller, Volkmar Müller, Eugen Ruckhäberle, E. Schumacher-Wulf, Christoph Thomssen, Nadia Harbeck, Rachel Würstlein","doi":"10.1159/000535997","DOIUrl":"https://doi.org/10.1159/000535997","url":null,"abstract":"Background: The “International Consensus Conference for Advanced Breast Cancer” was initiated more than 10 years ago. The rationale was to standardize treatment of advanced breast cancer (ABC) based on available evidence and to ensure that all ABC patients worldwide receive adequate treatment and access to new therapies. Topics of ABC7: The 7th International Consensus Conference for ABC (ABC7) took place from November 9 to 11, 2023 – as in previous years in Lisbon/Portugal. ABC7 focused not only on metastatic disease but also on locally advanced and inflammatory breast cancer. Special topics were the management of oligometastatic disease, leptomeningeal disease, brain metastases, and pregnant women with ABC. Due to the current situation worldwide, there was a special interest to patients living in conflict zones. As in previous years, patient advocates from around the world were integrated into the ABC conference and had a major input to the consensus. Rationale for the Manuscript: A German breast cancer expert panel comments on the voting results of the ABC7 panelists regarding their relevance for routine clinical practice in Germany. As with previous meetings, the ABC7 votes focused on modified or new statements. Regarding the statements not modified for the ABC7 consensus, they are discussed in the published manuscript from 2021 in which the German experts commented on the ABC6 consensus. The German comments are always based on the current recommendations of the “Breast Committee” of the Gynecological Oncology Working Group (Arbeitsgemeinschaft Gynäkologische Onkologie, AGO Mamma).","PeriodicalId":504260,"journal":{"name":"Breast Care","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140497212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Breast CarePub Date : 2024-01-22DOI: 10.1159/000536413
Gail Wan Ying Chua, Lucia Li
{"title":"Treatment Options for Early Stage Inoperable Breast Cancer: Cryoablation or Radiotherapy?","authors":"Gail Wan Ying Chua, Lucia Li","doi":"10.1159/000536413","DOIUrl":"https://doi.org/10.1159/000536413","url":null,"abstract":"Background: Surgical removal of the tumour is the gold standard treatment for early stage invasive breast cancer. However, with a global ageing population, a larger number of diagnoses are occurring in women with comorbidities that render them unsuitable for surgery. Hence, it is of interest to explore alternative treatment strategies for this group of women. Summary: Our narrative review aims to explore two such techniques, cryoablation and external beam radiotherapy, providing a brief summary of the evidence behind each technique. Following this, we discuss which groups of patients would gain the most benefit from each technique. Factors favouring the use of radiotherapy include patients with larger tumours, more superficial tumours, and those with less well-demarcated tumours where there is uncertainty regarding tumour extent. Meanwhile, patients who may benefit more from cryoablation include those who desire a smaller number of treatment sessions, have concerns regarding cosmesis and skin pigmentation, or who have relative contraindications to radiotherapy such as scleroderma, systemic lupus erythematosus, reduced lung function, or cardiac comorbidities. Key Messages: Continued advancements in both cryoablation and radiotherapy technologies are taking place, in tandem with imaging technologies enabling greater certainty in tumour detection and delineation. These factors will help increase local control rates in this group of non-operable early stage breast cancer patients. Through this review, we hope to aid in the clinical decision-making process regarding the selection and referral of patients for each treatment.","PeriodicalId":504260,"journal":{"name":"Breast Care","volume":"57 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140499790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
